RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Chemical and Drug Induced Liver Injury
Accession: DOID:9007383
browse the term
Definition: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
Synonyms: exact_synonym: Chemically Induced Liver Toxicity; Drug Induced Acute Liver Injury; Drug Induced Liver Disease; Drug Induced Liver Injury; Drug-Induced Liver Diseases; Drug-Induced Liver Injuries; Toxic Hepatitis; chemically-induced liver toxicities; hepatotoxicity; toxic hepatitides
narrow_synonym: Drug-induced liver injury due to flucloxacillin
primary_id: MESH:D056486
alt_id: RDO:0007742
xref: EFO:0004228 ; EFO:0011052 ; NCI:C84427
GViewer not supported for the selected species.
G
Aass
aminoadipate-semialdehyde synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955479:3,746,003...3,805,835
Ensembl chrNW_004955479:3,742,757...3,814,338
G
Abcb1
ATP binding cassette subfamily B member 1
severity susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP::2677G>T/A(rs2032582)(human)
RGD CTD
PMID:20623750 PMID:26134275 PMID:27296832
RGD:11041130 RGD:14700895
NCBI chrNW_004955432:4,911,774...5,085,349
G
Abcb11
ATP binding cassette subfamily B member 11
severity
ISO
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
G
Abcc1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chrNW_004955442:729,322...858,826
Ensembl chrNW_004955442:729,316...860,290
G
Abcc2
ATP binding cassette subfamily C member 2
susceptibility
ISO
DNA:polymorphism:promoter:-24C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354
RGD:14700812 RGD:14700814
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
G
Abi1
abl interactor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955429:2,682,341...2,783,752
Ensembl chrNW_004955429:2,682,343...2,783,752
G
Acox3
acyl-CoA oxidase 3, pristanoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955514:2,653,502...2,690,452
Ensembl chrNW_004955514:2,656,144...2,685,896
G
Acsl1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955403:24,190,674...24,235,354
Ensembl chrNW_004955403:24,190,674...24,236,780
G
Actb
actin beta
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
CTD RGD
PMID:22563491 PMID:25231249
RGD:9587759
NCBI chrNW_004955460:10,358,100...10,361,585
Ensembl chrNW_004955460:10,356,699...10,361,585
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955468:770,573...841,859
Ensembl chrNW_004955468:770,573...842,209
G
Actr3
actin related protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955459:15,216,914...15,284,013
Ensembl chrNW_004955459:15,216,914...15,284,013
G
Ada
adenosine deaminase
ISO
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chrNW_004955445:12,696,096...12,717,488
Ensembl chrNW_004955445:12,696,096...12,717,488
G
Adam8
ADAM metallopeptidase domain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chrNW_004955477:10,894,288...10,906,961
Ensembl chrNW_004955477:10,895,446...10,907,215
G
Adipoq
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
G
Adipor2
adiponectin receptor 2
severity
ISO
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chrNW_004955454:4,243,898...4,327,255
Ensembl chrNW_004955454:4,243,898...4,327,308
G
Adora2b
adenosine A2b receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chrNW_004955467:1,342,271...1,363,149
Ensembl chrNW_004955467:1,342,271...1,363,138
G
Agt
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
G
Ahr
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:28959666 PMID:34848246
RGD:401794432
NCBI chrNW_004955410:20,428,531...20,459,482
Ensembl chrNW_004955410:20,428,546...20,456,836
G
Aifm1
apoptosis inducing factor mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chrNW_004955473:4,891,955...4,925,705
Ensembl chrNW_004955473:4,891,955...4,926,428
G
Ak4
adenylate kinase 4
ISO
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chrNW_004955423:25,395,086...25,402,324
Ensembl chrNW_004955423:25,395,836...25,427,474
G
Akr1a1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29763686 PMID:32805337
RGD:27226688
NCBI chrNW_004955464:12,715,238...12,729,034
Ensembl chrNW_004955464:12,714,717...12,729,662
G
Alb
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chrNW_004955447:9,327...21,212
G
Aldh1l2
aldehyde dehydrogenase 1 family member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955405:39,387,949...39,437,282
Ensembl chrNW_004955405:39,387,527...39,437,322
G
Aldh2
aldehyde dehydrogenase 2 family member
severity susceptibility
ISO
DNA:deletion:exon 3 (mouse) protein:increased expression:liver
RGD
PMID:21138988 PMID:24492981 PMID:30121625
RGD:14975148 RGD:15036810 RGD:7241599
NCBI chrNW_004955482:8,352,569...8,383,097
Ensembl chrNW_004955482:8,352,569...8,384,899
G
Aldh9a1
aldehyde dehydrogenase 9 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955462:10,998,147...11,017,360
G
Aldob
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chrNW_004955419:24,377,427...24,389,909
Ensembl chrNW_004955419:24,377,427...24,389,909
G
Ambp
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chrNW_004955419:13,478,904...13,492,329
Ensembl chrNW_004955419:13,478,552...13,492,327
G
Anxa2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
G
Anxa6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955408:2,522,027...2,565,862
Ensembl chrNW_004955408:2,522,027...2,570,426
G
Apoa1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
G
Apoe
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
G
Apoh
apolipoprotein H
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:plasma:
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chrNW_004955478:5,612,258...5,626,061
Ensembl chrNW_004955478:5,610,164...5,626,020
G
Arg1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chrNW_004955436:12,235,767...12,247,817
Ensembl chrNW_004955436:12,235,767...12,251,972
G
Arnt
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
NCBI chrNW_004955588:159,462...233,047
Ensembl chrNW_004955588:159,462...233,047
G
Atg5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chrNW_004955411:31,501,191...31,646,407
Ensembl chrNW_004955411:31,522,420...31,646,827
G
Atoh8
atonal bHLH transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955424:1,775,139...1,803,106
Ensembl chrNW_004955424:1,776,127...1,802,763
G
Atp6v1d
ATPase H+ transporting V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955466:2,855,597...2,869,319
Ensembl chrNW_004955466:2,854,889...2,869,950
G
Bad
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chrNW_004955422:20,795,585...20,809,039
Ensembl chrNW_004955422:20,795,676...20,809,245
G
Bax
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chrNW_004955559:1,695,960...1,700,246
Ensembl chrNW_004955559:1,695,960...1,700,244
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955420:13,454,379...13,486,700
Ensembl chrNW_004955420:13,452,166...13,486,565
G
Bdkrb2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chrNW_004955438:16,514,300...16,537,160
Ensembl chrNW_004955438:16,511,759...16,537,172
G
Blvrb
biliverdin reductase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955578:813,834...834,675
Ensembl chrNW_004955578:813,480...838,151
G
Bmal1
basic helix-loop-helix ARNT like 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chrNW_004955414:28,652,663...28,748,360
Ensembl chrNW_004955414:28,684,226...28,748,360
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955520:3,521,096...3,543,255
Ensembl chrNW_004955520:3,524,684...3,544,666
G
Brd4
bromodomain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955495:7,959,033...7,989,216
Ensembl chrNW_004955495:7,957,510...7,988,498
G
Btd
biotinidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chrNW_004955430:7,960,036...7,988,754
Ensembl chrNW_004955430:7,960,039...7,988,754
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955495:2,796,601...2,824,233
Ensembl chrNW_004955495:2,796,663...2,824,697
G
Ca3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chrNW_004955417:3,362,091...3,372,270
Ensembl chrNW_004955417:3,362,492...3,372,932
G
Cabp1
calcium binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chrNW_004955455:11,000,763...11,068,922
G
Cadps2
calcium dependent secretion activator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955479:3,961,877...4,485,710
Ensembl chrNW_004955479:3,961,731...4,485,710
G
Canx
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955408:850,773...894,362
Ensembl chrNW_004955408:848,808...894,362
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955452:17,503,530...17,528,049
Ensembl chrNW_004955452:17,503,531...17,528,049
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chrNW_004955403:322,082...348,591
Ensembl chrNW_004955403:322,555...347,053
G
Cast
calpastatin
ISO
RGD
PMID:16871587
RGD:5683869
NCBI chrNW_004955418:15,859,951...15,974,141
Ensembl chrNW_004955418:15,862,729...15,916,169
G
Cat
catalase
ISO
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:21138988 PMID:25231249
RGD:7241599
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
G
Ccdc80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955427:12,945,230...12,975,020
Ensembl chrNW_004955427:12,945,230...12,975,114
G
Ccr2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955420:25,641,184...25,664,413
G
Cct3
chaperonin containing TCP1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955545:2,444,988...2,460,976
Ensembl chrNW_004955545:2,444,988...2,461,113
G
Cct5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955426:132,106...144,251
Ensembl chrNW_004955426:131,871...144,354
G
Cdc25b
cell division cycle 25B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955415:14,637,295...14,647,181
Ensembl chrNW_004955415:14,629,132...14,650,116
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955474:5,057,833...5,104,235
Ensembl chrNW_004955474:5,057,833...5,104,235
G
Cela1
chymotrypsin like elastase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955547:1,810,680...1,823,938
Ensembl chrNW_004955547:1,810,670...1,824,409
G
Cfap20
cilia and flagella associated protein 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955433:15,648,529...15,663,308
Ensembl chrNW_004955433:15,648,099...15,663,502
G
Chrm3
cholinergic receptor muscarinic 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chrNW_004955492:958,347...1,429,832
Ensembl chrNW_004955492:958,949...960,721
G
Ckb
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955538:2,379,868...2,380,771
G
Clu
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955403:50,160,598...50,175,876
Ensembl chrNW_004955403:50,160,598...50,175,876
G
Col14a1
collagen type XIV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955417:25,579,547...25,774,067
Ensembl chrNW_004955417:25,579,547...25,774,127
G
Col3a1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chrNW_004955403:9,720,831...9,758,019
Ensembl chrNW_004955403:9,721,114...9,757,887
G
Comt
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chrNW_004955442:18,130,282...18,152,153
Ensembl chrNW_004955442:18,130,987...18,137,412
G
Coq9
coenzyme Q9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955433:15,081,390...15,094,441
Ensembl chrNW_004955433:15,081,390...15,094,441
G
Cp
ceruloplasmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
G
Cpb2
carboxypeptidase B2
ISO
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chrNW_004955518:3,740,348...3,803,540
Ensembl chrNW_004955518:3,740,348...3,803,539
G
Cps1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955457:4,848,116...4,961,384
Ensembl chrNW_004955457:4,844,152...4,961,246
G
Cpt1a
carnitine palmitoyltransferase 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chrNW_004955422:17,105,887...17,159,696
Ensembl chrNW_004955422:17,109,256...17,159,838
G
Csf3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20005281 PMID:33882750
NCBI chrNW_004955451:14,688,181...14,690,126
Ensembl chrNW_004955451:14,688,181...14,690,126
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chrNW_004955420:29,030,716...29,047,447
Ensembl chrNW_004955420:29,030,716...29,047,449
G
Ctse
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955406:41,641,412...41,653,261
Ensembl chrNW_004955406:41,641,311...41,653,296
G
Cxcl10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
G
Cxcl14
C-X-C motif chemokine ligand 14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38614205
NCBI chrNW_004955408:30,733,079...30,740,854
Ensembl chrNW_004955408:30,733,079...30,740,854
G
Dbt
dihydrolipoamide branched chain transacylase E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955435:4,975,664...5,005,126
Ensembl chrNW_004955435:4,973,830...5,017,816
G
Ddb1
damage specific DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955511:6,209,777...6,233,594
Ensembl chrNW_004955511:6,209,777...6,233,594
G
Dgat2
diacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chrNW_004955414:16,059,781...16,089,727
Ensembl chrNW_004955414:16,059,781...16,089,727
G
Dhfr
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chrNW_004955418:29,274,170...29,283,028
G
Dlat
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955412:13,718,091...13,746,220
Ensembl chrNW_004955412:13,718,067...13,744,239
G
Dnajb9
DnaJ heat shock protein family (Hsp40) member B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955410:12,814,993...12,820,852
Ensembl chrNW_004955410:12,814,479...12,822,777
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955425:20,202,264...20,236,416
Ensembl chrNW_004955425:20,200,239...20,236,408
G
Dsc2
desmocollin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955402:18,465,631...18,496,948
Ensembl chrNW_004955402:18,464,989...18,489,475
G
E2f1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chrNW_004955422:27,638,625...27,643,261
Ensembl chrNW_004955422:27,633,827...27,642,241
G
Echdc1
ethylmalonyl-CoA decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955436:8,332,066...8,365,200
Ensembl chrNW_004955436:8,332,066...8,365,200
G
Echs1
enoyl-CoA hydratase, short chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955477:11,012,451...11,021,487
Ensembl chrNW_004955477:11,012,451...11,021,486
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955421:8,196,631...8,225,561
Ensembl chrNW_004955421:8,196,557...8,225,561
G
Eif2ak1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chrNW_004955460:13,723,674...13,754,545
Ensembl chrNW_004955460:13,723,777...13,754,150
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955437:20,844,750...20,879,874
Ensembl chrNW_004955437:20,844,750...20,879,885
G
Endog
endonuclease G
ISO
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chrNW_004955570:1,200,461...1,203,566
Ensembl chrNW_004955570:1,200,996...1,203,566
G
Eng
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chrNW_004955419:818,797...853,319
Ensembl chrNW_004955419:818,932...852,694
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chrNW_004955486:4,275,371...4,287,152
Ensembl chrNW_004955486:4,274,238...4,289,809
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chrNW_004955417:25,308,424...25,384,307
Ensembl chrNW_004955417:25,308,361...25,384,443
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955520:116,363...142,983
Ensembl chrNW_004955520:116,363...128,665
G
Erlec1
endoplasmic reticulum lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955441:19,535,425...19,557,960
Ensembl chrNW_004955441:19,535,425...19,557,458
G
Ern1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chrNW_004955478:7,720,664...7,803,662
Ensembl chrNW_004955478:7,751,830...7,799,460
G
F13a1
coagulation factor XIII A chain
ISO
RGD
PMID:22019897
RGD:11041813
NCBI chrNW_004955465:7,444,118...7,617,366
Ensembl chrNW_004955465:7,443,166...7,617,436
G
F2rl3
F2R like thrombin or trypsin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chrNW_004955524:1,045,493...1,047,924
Ensembl chrNW_004955524:1,044,792...1,047,819
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chrNW_004955423:254,060...264,448
Ensembl chrNW_004955423:254,189...264,159
G
Fadd
Fas associated via death domain
treatment
ISO
RGD
PMID:25447754 PMID:26062544
RGD:10053709 RGD:11341803
NCBI chrNW_004955422:16,026,323...16,035,808
Ensembl chrNW_004955422:16,031,280...16,036,281
G
Fads1
fatty acid desaturase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955511:5,908,394...5,915,764
Ensembl chrNW_004955511:5,907,726...5,915,764
G
Fads2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955511:5,827,797...5,842,745
Ensembl chrNW_004955511:5,827,797...5,842,760
G
Fas
Fas cell surface death receptor
ISO
protein:increased expression:liver (rat)
RGD
PMID:16831245
RGD:8662853
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
G
Fasn
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955506:1,063,002...1,079,939
Ensembl chrNW_004955506:1,063,002...1,079,939
G
Fcmr
Fc mu receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955406:42,438,173...42,452,339
Ensembl chrNW_004955406:42,438,783...42,452,163
G
Fga
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
G
Fgf21
fibroblast growth factor 21
severity
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chrNW_004955559:1,818,400...1,821,423
Ensembl chrNW_004955559:1,817,110...1,820,417
G
Flt1
fms related receptor tyrosine kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chrNW_004955497:7,653,309...7,831,737
Ensembl chrNW_004955497:7,653,248...7,831,472
G
Ftl
ferritin light chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955559:1,691,722...1,693,381
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chrNW_004955451:16,672,512...16,680,001
Ensembl chrNW_004955451:16,672,979...16,680,001
G
G6pd
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:21864513
RGD:10449168
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
G
Gadd45a
growth arrest and DNA damage inducible alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955423:23,656,516...23,658,367
Ensembl chrNW_004955423:23,656,458...23,658,367
G
Ganab
glucosidase II alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955599:556,510...569,891
Ensembl chrNW_004955599:556,362...573,353
G
Gc
GC vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955447:1,361,698...1,400,633
Ensembl chrNW_004955447:1,361,566...1,402,491
G
Gclc
glutamate-cysteine ligase catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17573345 PMID:19481141
RGD:10402383
NCBI chrNW_004955411:2,593,523...2,617,553
Ensembl chrNW_004955411:2,593,541...2,616,539
G
Gclm
glutamate-cysteine ligase modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955423:782,468...805,384
Ensembl chrNW_004955423:782,468...805,384
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955434:983,388...1,050,413
Ensembl chrNW_004955434:983,388...1,049,948
G
Gdi1
GDP dissociation inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955580:935,021...941,081
Ensembl chrNW_004955580:934,798...941,081
G
Gfer
growth factor, augmenter of liver regeneration
treatment
ISO
RGD
PMID:15968720 PMID:22033404
RGD:9685722 RGD:9685727
NCBI chrNW_004955442:15,280,753...15,283,405
Ensembl chrNW_004955442:15,281,419...15,283,266
G
Ggh
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chrNW_004955444:15,901,225...15,930,358
Ensembl chrNW_004955444:15,900,485...15,931,338
G
Ggt1
gamma-glutamyltransferase 1
ISO
RGD
PMID:10934156
RGD:14701049
NCBI chrNW_004955455:8,082,578...8,099,523
G
Ghrl
ghrelin and obestatin prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34151639
NCBI chrNW_004955561:1,676,475...1,682,205
Ensembl chrNW_004955561:1,676,576...1,681,812
G
Glud1
glutamate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chrNW_004955510:5,987,811...6,021,001
G
Got1
glutamic-oxaloacetic transaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955507:5,346,937...5,370,072
Ensembl chrNW_004955507:5,346,838...5,370,072
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955547:676,661...683,906
Ensembl chrNW_004955547:676,342...690,777
G
Gpt
glutamic--pyruvic transaminase
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum:
CTD RGD
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 PMID:28487901 More...
RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
G
Gpt2
glutamic--pyruvic transaminase 2
ISO
protein:increased expression, activity:serum:
RGD
PMID:19085960
RGD:14975249
NCBI chrNW_004955474:8,248,622...8,285,449
Ensembl chrNW_004955474:8,250,759...8,285,227
G
Grk4
G protein-coupled receptor kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955514:1,837,141...1,895,785
Ensembl chrNW_004955514:1,837,141...1,895,785
G
Gsn
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955419:6,682,202...6,733,361
Ensembl chrNW_004955419:6,682,058...6,733,361
G
Gsr
glutathione-disulfide reductase
treatment
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987
RGD:10401878 RGD:7257532
NCBI chrNW_004955463:7,130,459...7,153,631
Ensembl chrNW_004955463:7,131,364...7,153,583
G
Gstm3
glutathione S-transferase mu 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chrNW_004955435:13,253,947...13,256,965
Ensembl chrNW_004955435:13,253,947...13,256,965
G
Gstm4
glutathione S-transferase mu 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955435:13,064,691...13,069,734
Ensembl chrNW_004955435:13,063,966...13,210,264
G
Gstp1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
G
Hacl1
2-hydroxyacyl-CoA lyase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955430:2,055,774...2,096,260
Ensembl chrNW_004955430:2,053,640...2,096,432
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955469:8,183,945...8,233,869
Ensembl chrNW_004955469:8,183,945...8,233,869
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
G
Hao2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955435:22,380,395...22,404,426
Ensembl chrNW_004955435:22,380,388...22,404,052
G
Havcr1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955408:11,047,679...11,070,492
G
Hmgb1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chrNW_004955431:15,373,207...15,377,339
Ensembl chrNW_004955431:15,373,207...15,377,339
G
Hmox1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 RGD:15090820
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chrNW_004955482:6,586,975...6,595,034
Ensembl chrNW_004955482:6,586,975...6,595,034
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955473:462,940...510,006
G
Hpx
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955414:22,158,654...22,169,133
Ensembl chrNW_004955414:22,156,819...22,169,631
G
Hrh2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chrNW_004955408:28,186,316...28,225,146
Ensembl chrNW_004955408:28,186,249...28,229,411
G
Hspa5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955419:3,055,420...3,060,208
Ensembl chrNW_004955419:3,055,420...3,062,131
G
Hspa8
heat shock protein family A (Hsp70) member 8
ISO
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chrNW_004955412:23,863,513...23,867,984
Ensembl chrNW_004955412:23,862,590...23,867,984
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:31121248
RGD:14985250
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
G
Ido2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chrNW_004955536:2,894,410...2,938,862
Ensembl chrNW_004955536:2,894,308...2,939,016
G
Ifng
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
G
Igf1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
G
Il11
interleukin 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chrNW_004955567:868,272...883,563
Ensembl chrNW_004955567:871,489...883,563
G
Il12b
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chrNW_004955408:13,302,506...13,316,300
Ensembl chrNW_004955408:13,304,219...13,312,620
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chrNW_004955411:5,896,435...5,899,911
Ensembl chrNW_004955411:5,896,702...5,900,962
G
Il18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
G
Il1a
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
G
Il1b
interleukin 1 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 PMID:31077717 PMID:31342809 More...
RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
G
Il1r2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chrNW_004955470:7,518,565...7,562,219
Ensembl chrNW_004955470:7,518,663...7,559,470
G
Il22
interleukin 22
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chrNW_004955458:14,747,339...14,755,602
Ensembl chrNW_004955458:14,747,084...14,752,553
G
Il4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chrNW_004955408:4,058,052...4,065,999
G
Il6
interleukin 6
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chrNW_004955410:25,079,835...25,084,390
G
Immt
inner membrane mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955424:1,438,158...1,476,552
Ensembl chrNW_004955424:1,438,158...1,476,552
G
Irak1
interleukin 1 receptor associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955580:663,651...668,622
Ensembl chrNW_004955580:661,609...668,622
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chrNW_004955524:3,176,849...3,177,936
G
Keap1
kelch like ECH associated protein 1
ISO
RGD
PMID:18417483
RGD:6893370
NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chrNW_004955405:25,816,137...25,969,006
Ensembl chrNW_004955405:25,886,447...25,969,395
G
Kng1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chrNW_004955420:20,989,197...21,016,084
G
Krt18
keratin 18
ISO
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17340120 PMID:19783637 PMID:33483742 PMID:38521541
RGD:18337498
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
G
Krt8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955458:178,954...190,310
G
Lap3
leucine aminopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955480:6,565,071...6,588,682
Ensembl chrNW_004955480:6,560,718...6,588,682
G
Lcat
lecithin-cholesterol acyltransferase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chrNW_004955484:8,772,692...8,776,122
Ensembl chrNW_004955484:8,772,692...8,776,122
G
Ldlr
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chrNW_004955495:2,114,702...2,135,584
Ensembl chrNW_004955495:2,114,434...2,138,056
G
Lgals3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chrNW_004955409:8,448,120...8,452,437
Ensembl chrNW_004955409:8,447,774...8,452,438
G
Lipc
lipase C, hepatic type
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chrNW_004955450:15,947,869...16,062,449
Ensembl chrNW_004955450:15,948,187...16,048,766
G
LOC102009223
cytochrome P450 1B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chrNW_004955441:5,803,397...5,812,131
Ensembl chrNW_004955441:5,803,032...5,812,131
G
LOC102010322
cytochrome P450 1A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
G
LOC102010850
cytochrome P450 1A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chrNW_004955450:3,183,958...3,189,488
Ensembl chrNW_004955450:3,183,750...3,189,488
G
LOC102011841
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial
ISO
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chrNW_004955458:5,472,404...5,477,001
Ensembl chrNW_004955458:5,472,404...5,477,001
G
LOC102019604
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chrNW_004955420:27,988,067...27,990,637
G
LOC102021597
alpha-1-antiproteinase S-like
susceptibility
ISO
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human)
RGD
PMID:11140575 PMID:20170533
RGD:14695048 RGD:1643168
NCBI chrNW_004955438:17,920,200...17,929,105
G
LOC102025775
histone H2AX
treatment
ISO
RGD
PMID:23265463
RGD:8693741
NCBI chrNW_004955412:20,203,173...20,204,714
Ensembl chrNW_004955412:20,203,772...20,204,203
G
LOC102026028
cytochrome P450 2E1
treatment
ISO
DNA:hypermethylation:promoter associated with Endotoxemia CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 PMID:27490558 PMID:27960551 PMID:28762043 PMID:29404441 More...
RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
LOC102027549
serotransferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955501:4,801,710...4,832,025
Ensembl chrNW_004955501:4,801,885...4,831,910
G
Lpl
lipoprotein lipase
treatment
ISO
RGD
PMID:27071702
RGD:13794380
NCBI chrNW_004955403:43,646,084...43,672,116
Ensembl chrNW_004955403:43,646,084...43,673,967
G
Lrat
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955471:2,603,395...2,610,988
Ensembl chrNW_004955471:2,603,678...2,609,079
G
Ltb4r
leukotriene B4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chrNW_004955409:35,984,757...35,991,492
Ensembl chrNW_004955409:35,984,933...35,985,976
G
Ltf
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chrNW_004955420:25,580,449...25,604,277
Ensembl chrNW_004955420:25,580,359...25,604,331
G
Map1lc3b
microtubule associated protein 1 light chain 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955541:1,852,388...1,868,194
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chrNW_004955439:162,499...376,919
Ensembl chrNW_004955439:163,103...377,808
G
Mat1a
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955510:283,860...300,991
Ensembl chrNW_004955510:281,331...300,985
G
Mccc1
methylcrotonyl-CoA carboxylase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955420:11,781,662...11,828,060
Ensembl chrNW_004955420:11,781,104...11,820,338
G
Mdh1
malate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955424:20,707,765...20,723,493
Ensembl chrNW_004955424:20,706,058...20,723,493
G
Me1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955411:10,938,580...11,084,171
Ensembl chrNW_004955411:10,938,944...11,065,085
G
Med1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chrNW_004955451:14,204,326...14,237,809
Ensembl chrNW_004955451:14,202,744...14,237,797
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
G
Mmp9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
G
Mst1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955532:1,590,685...1,595,655
Ensembl chrNW_004955532:1,590,755...1,595,148
G
Mst1r
macrophage stimulating 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chrNW_004955532:1,774,726...1,789,662
Ensembl chrNW_004955532:1,775,033...1,787,990
G
Mthfr
methylenetetrahydrofolate reductase
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
G
Mtpn
myotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955494:6,805,518...6,844,454
Ensembl chrNW_004955494:6,805,262...6,845,394
G
Myd88
MYD88 innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:17615358
RGD:150521532
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955422:713,370...717,926
Ensembl chrNW_004955422:709,784...717,926
G
Nfatc4
nuclear factor of activated T cells 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chrNW_004955409:35,931,208...35,941,555
Ensembl chrNW_004955409:35,931,173...35,940,696
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
ISO
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620) CTD Direct Evidence: therapeutic
RGD CTD
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:29091898 PMID:30215777 PMID:31889292 PMID:31927046 PMID:31972209 PMID:32066295 More...
RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
G
Nfkb1
nuclear factor kappa B subunit 1
susceptibility treatment
ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 RGD:40902984
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
G
Nfxl1
nuclear transcription factor, X-box binding like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955443:665,235...714,627
Ensembl chrNW_004955443:668,031...713,481
G
Notch1
notch receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chrNW_004955513:4,225,939...4,264,875
Ensembl chrNW_004955513:4,225,956...4,263,259
G
Nox4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955414:4,062,337...4,220,032
Ensembl chrNW_004955414:4,062,081...4,212,746
G
Nqo1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28472605 PMID:28522909 PMID:29091898
RGD:13439737 RGD:13439739 RGD:15090820
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
G
Nr0b2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chrNW_004955452:6,251,047...6,253,541
Ensembl chrNW_004955452:6,250,889...6,254,541
G
Nr1d1
nuclear receptor subfamily 1 group D member 1
treatment
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chrNW_004955451:14,743,763...14,750,903
Ensembl chrNW_004955451:14,742,735...14,750,999
G
Nr1h3
nuclear receptor subfamily 1 group H member 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
G
Nr1h4
nuclear receptor subfamily 1 group H member 4
severity treatment
ISO
mRNA:decreased expression:liver (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression:liver (rat)
RGD CTD
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 PMID:30068870 More...
RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
G
Nr1i2
nuclear receptor subfamily 1 group I member 2
susceptibility
ISO
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chrNW_004955427:19,459,936...19,487,276
Ensembl chrNW_004955427:19,459,936...19,487,276
G
Nr1i3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chrNW_004955468:12,985,105...13,002,850
G
Nr2f2
nuclear receptor subfamily 2 group F member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955416:24,148,052...24,154,406
Ensembl chrNW_004955416:24,141,888...24,168,585
G
Nr5a2
nuclear receptor subfamily 5 group A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chrNW_004955406:36,263,257...36,415,494
Ensembl chrNW_004955406:36,263,184...36,415,525
G
Nrep
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955418:3,435,784...3,464,667
Ensembl chrNW_004955418:3,436,731...3,464,667
G
Ntn1
netrin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chrNW_004955467:7,795,175...7,991,597
Ensembl chrNW_004955467:7,794,735...7,991,695
G
Nus1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chrNW_004955436:825,387...850,558
Ensembl chrNW_004955436:825,387...850,558
G
Ociad1
OCIA domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955447:18,844,270...18,870,368
Ensembl chrNW_004955447:18,844,270...18,870,368
G
Ogdh
oxoglutarate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955456:7,416,343...7,484,889
Ensembl chrNW_004955456:7,415,589...7,485,515
G
P4hb
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955506:1,307,932...1,322,011
Ensembl chrNW_004955506:1,307,932...1,324,027
G
Pah
phenylalanine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955405:37,848,486...37,909,163
Ensembl chrNW_004955405:37,846,354...37,909,457
G
Pan2
poly(A) specific ribonuclease subunit PAN2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955458:3,925,356...3,946,879
Ensembl chrNW_004955458:3,926,070...3,941,506
G
Panx1
pannexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chrNW_004955414:405,483...448,470
Ensembl chrNW_004955414:401,188...448,470
G
Park7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955486:4,974,130...4,985,927
Ensembl chrNW_004955486:4,969,497...4,985,885
G
Pc
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955422:18,421,100...18,536,591
Ensembl chrNW_004955422:18,420,596...18,536,436
G
Pcolce
procollagen C-endopeptidase enhancer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955573:299,443...304,672
Ensembl chrNW_004955573:299,521...304,325
G
Pcyt1a
phosphate cytidylyltransferase 1A, choline
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955420:12,464,857...12,513,017
Ensembl chrNW_004955420:12,464,857...12,500,574
G
Pdk4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chrNW_004955432:12,169,548...12,182,064
Ensembl chrNW_004955432:12,169,435...12,182,409
G
Pdlim5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955405:5,109,778...5,312,192
Ensembl chrNW_004955405:5,109,778...5,315,092
G
Pex11a
peroxisomal biogenesis factor 11 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955416:15,527,925...15,537,497
Ensembl chrNW_004955416:15,527,941...15,534,424
G
Pgm1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955423:26,408,775...26,437,527
Ensembl chrNW_004955423:26,408,595...26,437,527
G
Plat
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chrNW_004955536:730,962...754,333
Ensembl chrNW_004955536:730,981...756,394
G
Plg
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chrNW_004955439:20,317,814...20,366,724
Ensembl chrNW_004955439:20,317,552...20,366,475
G
Pls3
plastin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955490:125,913...221,152
Ensembl chrNW_004955490:122,328...221,388
G
Pnp
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955550:1,290,816...1,299,553
Ensembl chrNW_004955550:1,290,244...1,298,068
G
Pnrc1
proline rich nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955411:15,837,491...15,841,277
Ensembl chrNW_004955411:15,837,747...15,840,641
G
Polg
DNA polymerase gamma, catalytic subunit
susceptibility no_association
ISO
DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039297 RGD:15039302
NCBI chrNW_004955416:15,773,005...15,788,736
Ensembl chrNW_004955416:15,773,473...15,788,651
G
Polr2g
RNA polymerase II subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955599:469,233...471,761
Ensembl chrNW_004955599:464,879...471,976
G
Pon1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
LPS-induced acute liver damage CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21262334 PMID:24385052 PMID:38181850
RGD:5509941
NCBI chrNW_004955413:30,306,563...30,366,245
Ensembl chrNW_004955413:30,307,219...30,359,500
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chrNW_004955429:14,814,690...14,936,869
Ensembl chrNW_004955429:14,873,908...14,937,387
G
Pptc7
protein phosphatase targeting COQ7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955482:7,445,218...7,484,939
Ensembl chrNW_004955482:7,445,218...7,484,952
G
Prkaa1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chrNW_004955426:25,079,718...25,102,090
Ensembl chrNW_004955426:25,079,718...25,102,090
G
Prkcd
protein kinase C delta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chrNW_004955430:3,125,066...3,151,857
Ensembl chrNW_004955430:3,124,738...3,153,274
G
Prkdc
protein kinase, DNA-activated, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chrNW_004955454:7,733,697...7,890,896
Ensembl chrNW_004955454:7,733,978...7,890,867
G
Ptf1a
pancreas associated transcription factor 1a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chrNW_004955429:5,807,804...5,809,522
Ensembl chrNW_004955429:5,808,124...5,809,522
G
Ptges2
prostaglandin E synthase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:31444509
NCBI chrNW_004955419:608,313...612,813
Ensembl chrNW_004955419:608,365...612,479
G
Ptgs2
prostaglandin-endoperoxide synthase 2
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
G
Pum1
pumilio RNA binding family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955452:9,487,725...9,623,565
Ensembl chrNW_004955452:9,487,725...9,624,066
G
Pygl
glycogen phosphorylase L
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chrNW_004955409:11,970,112...12,007,102
Ensembl chrNW_004955409:11,970,112...12,007,102
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955418:23,807,740...23,897,699
Ensembl chrNW_004955418:23,807,740...23,897,707
G
Rbp1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955508:6,046,738...6,072,202
Ensembl chrNW_004955508:6,046,316...6,072,288
G
Rdh13
retinol dehydrogenase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chrNW_004955567:1,091,636...1,108,648
Ensembl chrNW_004955567:1,091,636...1,108,732
G
Reep5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955418:2,504,028...2,539,574
Ensembl chrNW_004955418:2,502,674...2,536,817
G
Rgn
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955516:958,416...978,829
Ensembl chrNW_004955516:955,680...978,910
G
Ripk3
receptor interacting serine/threonine kinase 3
ISO
protein:increased expression:liver (mouse) CTD Direct Evidence: therapeutic
RGD CTD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chrNW_004955409:35,961,604...35,965,477
Ensembl chrNW_004955409:35,937,880...35,965,712
G
S100a11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955589:405,544...409,936
Ensembl chrNW_004955589:408,319...413,971
G
Scarb1
scavenger receptor class B member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chrNW_004955482:4,813,502...4,836,479
Ensembl chrNW_004955482:4,813,955...4,837,392
G
Selenbp1
selenium binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955588:703,928...713,941
Ensembl chrNW_004955588:703,928...714,763
G
Sema3a
semaphorin 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chrNW_004955410:2,146,088...2,344,342
Ensembl chrNW_004955410:2,144,388...2,338,973
G
Sema4a
semaphorin 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chrNW_004955545:2,316,402...2,341,873
Ensembl chrNW_004955545:2,316,390...2,342,233
G
Senp2
SUMO specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chrNW_004955420:21,969,537...22,005,094
Ensembl chrNW_004955420:21,969,537...22,005,856
G
Serpina6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955438:16,356,600...16,380,861
Ensembl chrNW_004955438:16,356,540...16,380,872
G
Serpine1
serpin family E member 1
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
G
Serping1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955511:2,545,337...2,557,850
Ensembl chrNW_004955511:2,545,285...2,557,982
G
Sesn2
sestrin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chrNW_004955452:7,392,644...7,417,204
Ensembl chrNW_004955452:7,393,007...7,417,304
G
Sgf29
SAGA complex associated factor 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955493:6,759,426...6,774,796
Ensembl chrNW_004955493:6,759,426...6,774,796
G
Shc1
SHC adaptor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chrNW_004955545:1,468,391...1,479,209
Ensembl chrNW_004955545:1,468,391...1,476,814
G
Slc10a1
solute carrier family 10 member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chrNW_004955466:597,081...609,254
Ensembl chrNW_004955466:597,204...608,756
G
Slc10a7
solute carrier family 10 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955428:1,999,341...2,250,201
Ensembl chrNW_004955428:1,999,280...2,250,234
G
Slc13a4
solute carrier family 13 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955494:7,013,577...7,057,767
Ensembl chrNW_004955494:7,014,252...7,055,514
G
Slc22a8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955599:284,038...299,603
Ensembl chrNW_004955599:283,929...300,796
G
Slc25a29
solute carrier family 25 member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955438:21,383,805...21,393,897
Ensembl chrNW_004955438:21,389,057...21,394,124
G
Slc7a5
solute carrier family 7 member 5
treatment
ISO
RGD
PMID:9200186
RGD:151357001
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
G
Snx18
sorting nexin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chrNW_004955446:13,043,821...13,067,933
Ensembl chrNW_004955446:13,043,821...13,067,933
G
Sod1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chrNW_004955407:31,261,451...31,267,657
Ensembl chrNW_004955407:31,263,863...31,267,727
G
Sod2
superoxide dismutase 2
susceptibility severity treatment
ISO
DNA:SNP:cds:p.Val16Ala(human) associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981
RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961
NCBI chrNW_004955439:21,209,101...21,223,538
Ensembl chrNW_004955439:21,209,101...21,224,163
G
Sod3
superoxide dismutase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chrNW_004955480:257,716...263,149
G
Sord
sorbitol dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chrNW_004955409:8,305,819...8,333,733
Ensembl chrNW_004955409:8,303,602...8,333,869
G
Sorl1
sortilin related receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955412:22,421,984...22,576,179
Ensembl chrNW_004955412:22,421,984...22,576,179
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
G
Srp72
signal recognition particle 72
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955447:14,519,978...14,552,758
Ensembl chrNW_004955447:14,519,064...14,552,758
G
Stat3
signal transducer and activator of transcription 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:38460807
NCBI chrNW_004955451:16,320,326...16,348,505
Ensembl chrNW_004955451:16,319,904...16,357,687
G
Stat4
signal transducer and activator of transcription 4
severity
ISO
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:23876342 PMID:24731448
RGD:25671417 RGD:25671422
NCBI chrNW_004955403:8,061,471...8,144,252
Ensembl chrNW_004955403:8,061,471...8,144,276
G
Sting1
stimulator of interferon response cGAMP interactor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chrNW_004955418:1,091,022...1,097,064
Ensembl chrNW_004955418:1,083,613...1,100,448
G
Sult2b1
sulfotransferase family 2B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chrNW_004955559:1,942,878...1,968,895
G
Suox
sulfite oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955458:3,584,390...3,589,764
Ensembl chrNW_004955458:3,585,482...3,590,559
G
Tagln2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955468:11,713,809...11,721,125
Ensembl chrNW_004955468:11,713,515...11,721,870
G
Taldo1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chrNW_004955476:11,356,601...11,364,573
Ensembl chrNW_004955476:11,356,603...11,364,259
G
Tbxa2r
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chrNW_004955495:5,539,382...5,557,441
Ensembl chrNW_004955495:5,539,889...5,557,441
G
Tctn1
tectonic family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chrNW_004955482:7,504,554...7,533,605
Ensembl chrNW_004955482:7,504,532...7,528,542
G
Tgfb1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:27516150
RGD:14995464
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
G
Tgfbr1
transforming growth factor beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chrNW_004955419:26,490,899...26,546,349
Ensembl chrNW_004955419:26,490,899...26,547,017
G
Thbs1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chrNW_004955416:6,490,034...6,506,419
Ensembl chrNW_004955416:6,489,451...6,506,419
G
Thpo
thrombopoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
NCBI chrNW_004955420:23,120,828...23,128,894
Ensembl chrNW_004955420:23,123,637...23,129,198
G
Tlr4
toll like receptor 4
disease_progression
ISO
RGD
PMID:17504260
RGD:14697733
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
G
Tlr5
toll like receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chrNW_004955520:1,544,840...1,562,081
Ensembl chrNW_004955520:1,556,523...1,559,093
G
Tlr9
toll like receptor 9
treatment severity
ISO
protein:increased expression: blood, neutrophil (human)
RGD
PMID:19164858 PMID:23509352 PMID:26457748
RGD:18337465 RGD:18337473 RGD:18337476
NCBI chrNW_004955532:3,828,645...3,832,699
Ensembl chrNW_004955532:3,828,775...3,832,582
G
Tmem117
transmembrane protein 117
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955500:3,097,088...3,566,616
Ensembl chrNW_004955500:3,087,715...3,568,105
G
Tmem164
transmembrane protein 164
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955490:5,673,204...5,850,427
Ensembl chrNW_004955490:5,673,145...5,850,427
G
Tmem38b
transmembrane protein 38B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955419:20,811,931...20,844,420
Ensembl chrNW_004955419:20,812,702...20,878,599
G
Tnf
tumor necrosis factor
treatment severity
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 PMID:11124822 PMID:14686721 PMID:15830285 PMID:17070847 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:29091898 PMID:31077717 PMID:31342809 PMID:37866487 More...
RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
G
Trpm2
transient receptor potential cation channel subfamily M member 2
ISO
RGD
PMID:24569808
RGD:9999438
NCBI chrNW_004955407:41,062,217...41,110,500
Ensembl chrNW_004955407:41,057,941...41,110,668
G
Ttr
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chrNW_004955402:18,921,235...18,927,976
Ensembl chrNW_004955402:18,921,274...18,928,108
G
Tubb4b
tubulin beta 4B class IVb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955513:5,237,050...5,239,370
Ensembl chrNW_004955513:5,235,629...5,239,370
G
Uba5
ubiquitin like modifier activating enzyme 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chrNW_004955501:5,841,516...5,864,304
Ensembl chrNW_004955501:5,841,606...5,870,953
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955422:17,814,174...17,823,945
Ensembl chrNW_004955422:17,814,079...17,824,190
G
Usp5
ubiquitin specific peptidase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955413:4,451,530...4,466,832
Ensembl chrNW_004955413:4,451,622...4,466,832
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17784864 PMID:25231249
RGD:15003197
NCBI chrNW_004955437:9,527,445...9,541,908
G
Vim
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955429:10,708,852...10,716,743
Ensembl chrNW_004955429:10,707,719...10,717,554
G
Vwf
von Willebrand factor
ISO
protein:increased expression:liver: CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:7531171 PMID:28527913
RGD:11079232
NCBI chrNW_004955413:3,672,470...3,825,588
Ensembl chrNW_004955413:3,672,470...3,819,571
G
Wasl
WASP like actin nucleation promoting factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955479:5,167,851...5,200,512
Ensembl chrNW_004955479:5,166,393...5,200,512
G
Xrcc1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chrNW_004955555:1,293,416...1,315,839
Ensembl chrNW_004955555:1,293,416...1,315,839
G
Xylb
xylulokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chrNW_004955427:25,492,505...25,528,674
Ensembl chrNW_004955427:25,492,505...25,528,740
G
Zdhhc23
zinc finger DHHC-type palmitoyltransferase 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chrNW_004955427:14,045,659...14,057,226
Ensembl chrNW_004955427:14,045,657...14,057,202
G
Abcc2
ATP binding cassette subfamily C member 2
no_association susceptibility
ISO
DNA:SNPs:multiple: DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human)
RGD
PMID:17502832 PMID:22178260
RGD:14700816 RGD:14700817
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16140414
RGD:2316848
NCBI chrNW_004955425:25,362,165...25,380,611
Ensembl chrNW_004955425:25,359,884...25,380,745
G
LOC102026028
cytochrome P450 2E1
ISO
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
G
Lpar1
lysophosphatidic acid receptor 1
ISO
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chrNW_004955419:16,190,109...16,324,702
Ensembl chrNW_004955419:16,191,244...16,325,602
G
Gpt
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:28921207
RGD:14975164
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all